183 related articles for article (PubMed ID: 12732887)
21. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
Elfenbein GJ; Sackstein R
Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
[TBL] [Abstract][Full Text] [Related]
22. Nosocomial infections in a Dutch neonatal intensive care unit: surveillance study with definitions for infection specifically adapted for neonates.
van der Zwet WC; Kaiser AM; van Elburg RM; Berkhof J; Fetter WP; Parlevliet GA; Vandenbroucke-Grauls CM
J Hosp Infect; 2005 Dec; 61(4):300-11. PubMed ID: 16221510
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants.
Ninin E; Milpied N; Moreau P; André-Richet B; Morineau N; Mahé B; Vigier M; Imbert BM; Morin O; Harousseau JL; Richet H
Clin Infect Dis; 2001 Jul; 33(1):41-7. PubMed ID: 11389493
[TBL] [Abstract][Full Text] [Related]
24. Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
Harter C; Schulze B; Goldschmidt H; Benner A; Geiss HK; Hoppe-Tichy T; Ho AD; Egerer G
Bone Marrow Transplant; 2006 Feb; 37(4):373-9. PubMed ID: 16400334
[TBL] [Abstract][Full Text] [Related]
25. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
[TBL] [Abstract][Full Text] [Related]
26. Surveillance for nosocomial infections and fever of unknown origin among adult hematology-oncology patients.
Engelhart S; Glasmacher A; Exner M; Kramer MH
Infect Control Hosp Epidemiol; 2002 May; 23(5):244-8. PubMed ID: 12026148
[TBL] [Abstract][Full Text] [Related]
27. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
[TBL] [Abstract][Full Text] [Related]
28. Nosocomial infections in a medical-surgical intensive care unit.
Aly NY; Al-Mousa HH; Al Asar el SM
Med Princ Pract; 2008; 17(5):373-7. PubMed ID: 18685276
[TBL] [Abstract][Full Text] [Related]
29. Oral ciprofloxacin as antibacterial prophylaxis after allogeneic bone marrow transplantation: a reappraisal.
Yeh SP; Hsueh EJ; Yu MS; Wu H; Wang YC
Bone Marrow Transplant; 1999 Dec; 24(11):1207-11. PubMed ID: 10642810
[TBL] [Abstract][Full Text] [Related]
30. Terminal deoxynucleotidyl transferase-positive cells in trephine biopsies following bone marrow or peripheral stem cell transplantation reflect vigorous B-cell generation.
Wolf E; Harms H; Winkler J; Reulbach U; Kirchner T; Niedobitek G; Baumann I
Histopathology; 2005 Apr; 46(4):442-50. PubMed ID: 15810956
[TBL] [Abstract][Full Text] [Related]
31. Incidence of bone marrow transplantation in Europe. Report from the European Group for Blood and Marrow Transplantation.
Gratwohl A
Arch Immunol Ther Exp (Warsz); 1995; 43(2):77-81. PubMed ID: 8744719
[TBL] [Abstract][Full Text] [Related]
32. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
33. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U
Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
[TBL] [Abstract][Full Text] [Related]
34. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
[TBL] [Abstract][Full Text] [Related]
35. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources.
Walker CM; van Burik JA; De For TE; Weisdorf DJ
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1106-15. PubMed ID: 17697973
[TBL] [Abstract][Full Text] [Related]
36. Fixed-dose single administration of Pegfilgrastim vs daily Filgrastim in patients with haematological malignancies undergoing autologous peripheral blood stem cell transplantation.
Staber PB; Holub R; Linkesch W; Schmidt H; Neumeister P
Bone Marrow Transplant; 2005 May; 35(9):889-93. PubMed ID: 15765110
[TBL] [Abstract][Full Text] [Related]
37. Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation.
Roghmann M; Ball K; Erdman D; Lovchik J; Anderson LJ; Edelman R
Bone Marrow Transplant; 2003 Dec; 32(11):1085-8. PubMed ID: 14625580
[TBL] [Abstract][Full Text] [Related]
38. Incidence of nosocomial urinary tract infections on a surgical intensive care unit and implications for management.
Wagenlehner FM; Loibl E; Vogel H; Naber KG
Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S86-90. PubMed ID: 16829050
[TBL] [Abstract][Full Text] [Related]
39. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders.
Kim DH; Messner H; Minden M; Gupta V; Kuruvilla J; Wright J; Lipton J
Transpl Infect Dis; 2008 Apr; 10(2):90-8. PubMed ID: 17605742
[TBL] [Abstract][Full Text] [Related]
40. Allogeneic versus autologous versus peripheral stem cell transplantation in CR1 pediatric AML patients: a single center experience.
Anak S; Saribeyoglu ET; Bilgen H; Unuvar A; Karakas Z; Devecioglu O; Agaoglu L; Gedikoglu G
Pediatr Blood Cancer; 2005 Jun; 44(7):654-9. PubMed ID: 15700262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
